KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results
J Allergy Clin Immunol. 2022 Jun;149(6):2034-2042. doi: 10.1016/j.jaci.2021.10.038. Epub 2022 Jan 24. ABSTRACT BACKGROUND: Attacks of hereditary angioedema are attributed to excessive plasma kallikrein (PKa)
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
bioRxiv. 2021 Mar 10:2021.03.10.434840. doi: 10.1101/2021.03.10.434840. Preprint. ABSTRACT Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with an unknown reach
